The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Healthrageous, the creator of a multi-tiered personalized health management tool, raised $6 million in a Series A equity sale.
North Bridge Venture Partners of Boston led the round and was joined by fellow Boston-based firm Egan Managed Capital and Long River Ventures of Amherst, Mass.
According to an SEC filing all of the $6 million in equity made available was sold.
Japanese doc uses iPad during surgery: A Japanese surgeon at Kobe University used an iPad to review abdominal CT images during surgery. The iPad is carefully wrapped in plastic, yet the touchscreen still seems to respond very well even to gloved fingers. 
By Mary Vanac
Israeli device company EarlySense raised $13 million to launch its EverOn patient monitoring system in the U.S. and Europe.
The Ramat Gan, Israel-based company last year received a grant from the Global Cardiovascular Innovation Center, led by the Cleveland Clinic.
More than 122 medical devices were infected by malware during the past 14 months at the U.S. Dept. of Veterans Affairs’ network of 50,000 medical devices, representing what one official called a critical challenge to the department’s security.
Coming soon: Touchscreen phones for the blind: Toshiba has been showing off new tactile feedback technology, originally developed by Senseg of Helsinki, Finland, that produces what feels like texture using a transparent electric surface layered on top of the screen. There’s actually no moving parts at all. If proven effective, this should allow for Braille on smartphones and input selection without even looking at the screen.
When it comes to routine ailments like soar throats, bladder infections, sinus infections and seasonal allergies, diagnosis and treatment are fairly standard.
So why should patients suffering from one of those ordinary conditions take time off from work, drive to the doctor’s office and sit in the waiting room when the outcome of an interaction with their doctor is often so predictable?
Medtronic Inc. (NYSE:MDT) and St. Jude Medical Inc. (NYSE:STJ) released similar wireless transmission devices designed to send data from patients’ implanted cardiac devices to physicians.
Each new device allows for patients to send data from their cardiac medical devices via cellular networks, rather than having to rely on dial-up phone lines.
Apple files patent for iPhone embedded heart monitor: Apple filed a patent for a seamlessly embedded heart monitor in what looks like an iPhone or iPod touch. The main purpose of the integration appears to be for authorization purposes. Using specific algorithms, an EKG tracing can be used to identify individuals. The patent also states that the embedded monitor can be used to predict a user’s mood, a feature of which we’re a bit skeptical.
iFall: An Android fall detection app: Researchers at Florida State University developed an alert system for the Android smartphone platform that both detects falls and alerts authorities. Data from the device’s accelerometer is evaluated using several threshold-based algorithms and positional data to determine a fall, taking into account factors such as height, weight and level of activity of the user. When a fall is detected, a notification is raised requiring the user to respond. If he or she does not respond, the system alerts family or friends via SMS.
Proteus Biomedical wins 510(k) for wireless personal health monitor: Proteus Biomedical of Redwood City, Calif., won 510(k) clearance from the Food & Drug Administration for its wireless Raisin Personal Monitor, a wearable device that records heart rate, physical activity, body position and patient-logged events and transmits the data via Bluetooth to mobile phones, mHealth systems or any computerized device.
Amid the cacophony of thousands of iPhone healthcare apps, Dan Bernstein thinks his has what it takes to break through the noise.
Bernstein’s app, Personal Caregiver, is targeted towards both health providers and consumers. The app reminds patients to take their medications, when to get refills and warns them of adverse drug interactions. For health providers, it helps them do the same for multiple patients.
